PRE CONFERENCE SYMPOSIUM
Date
09.03.2021, Tuesday
Session Time
13:30 - 17:20
Chair(s)
- Paul Edison, United Kingdom
- Christian Hölscher, China
- TBA, Antarctica
Session Icon
WELCOME AND INTRODUCTION
Session Name
Session Type
PRE CONFERENCE SYMPOSIUM
Date
09.03.2021, Tuesday
Session Time
13:30 - 17:20
Room
Pre-Conference 2
Lecture Time
13:30 - 13:40
Presenter
- Christian Hölscher, China
Session Icon
INTRANASAL INSULIN AS A THERAPY FOR ALZHEIMER’S DISEASE
Session Name
Session Type
PRE CONFERENCE SYMPOSIUM
Date
09.03.2021, Tuesday
Session Time
13:30 - 17:20
Room
Pre-Conference 2
Lecture Time
13:40 - 14:00
Presenter
- Suzanne Craft, United States of America
Session Icon
CLINICAL TRIAL OF BYDUREON (EXENATIDE) IN PD PATIENTS
Session Name
Session Type
PRE CONFERENCE SYMPOSIUM
Date
09.03.2021, Tuesday
Session Time
13:30 - 17:20
Room
Pre-Conference 2
Lecture Time
14:00 - 14:20
Presenter
- Tom Foltynie, United Kingdom
Session Icon
EVALUATION OF LIRAGLUTIDE IN THE TREATMENT OF ALZHEIMER'S DISEASE
Session Name
Session Type
PRE CONFERENCE SYMPOSIUM
Date
09.03.2021, Tuesday
Session Time
13:30 - 17:20
Room
Pre-Conference 2
Lecture Time
14:20 - 14:40
Presenter
- Paul Edison, United Kingdom
Session Icon
CLINICAL TRIAL OF LIRAGLUTIDE IN PD PATIENTS
Session Name
Session Type
PRE CONFERENCE SYMPOSIUM
Date
09.03.2021, Tuesday
Session Time
13:30 - 17:20
Room
Pre-Conference 2
Lecture Time
14:40 - 15:00
Presenter
- Michele Tagliati, United States of America
Session Icon
IMPAIRED BRAIN INSULIN SIGNALLING IN SYNUCLEINOPATHIES: A TRANSLATIONAL STUDY
Session Name
Session Type
PRE CONFERENCE SYMPOSIUM
Date
09.03.2021, Tuesday
Session Time
13:30 - 17:20
Room
Pre-Conference 2
Lecture Time
15:00 - 15:20
Presenter
- Wassilios Meissner, France
Session Icon
INSULIN SIGNALING BIOMARKERS IN BLOOD EXOSOMES OF AD AND PD PATIENTS
Session Name
Session Type
PRE CONFERENCE SYMPOSIUM
Date
09.03.2021, Tuesday
Session Time
13:30 - 17:20
Room
Pre-Conference 2
Lecture Time
15:20 - 15:40
Presenter
- Dimitrios Kapogiannis, United States of America
Session Icon
DIRECT DEMONSTRATION OF BRAIN INSULIN RESISTANCE IN ALZHEIMER’S AND PARKINSON’S DISEASE DEMENTIA AND ITS ALLEVIATION WITH INCRETIN RECEPTOR AGONISTS
Session Name
Session Type
PRE CONFERENCE SYMPOSIUM
Date
09.03.2021, Tuesday
Session Time
13:30 - 17:20
Room
Pre-Conference 2
Lecture Time
15:40 - 16:00
Presenter
- Konrad Talbot, United States of America
Session Icon
PERMEABILITY OF THE BLOOD-BRAIN BARRIER TO INSULIN AND INCRETINS
Session Name
Session Type
PRE CONFERENCE SYMPOSIUM
Date
09.03.2021, Tuesday
Session Time
13:30 - 17:20
Room
Pre-Conference 2
Lecture Time
16:00 - 16:20
Presenter
- William Banks, United States of America
Session Icon
GLUCAGON-LIKE PEPTIDE-1(GLP-1) RECEPTOR AGONISTS AS A TREATMENT STRATEGY FOR NEURODEGENERATIVE DISORDERS; FOCUSING ON PARKINSON'S DISEASE AND TRAUMATIC BRAIN INJURY
Session Name
Session Type
PRE CONFERENCE SYMPOSIUM
Date
09.03.2021, Tuesday
Session Time
13:30 - 17:20
Room
Pre-Conference 2
Lecture Time
16:20 - 16:40
Presenter
- Nigel H. Greig, United States of America
Session Icon
THE NEUROPROTECTIVE EFFECTS OF INSULIN/IGF-1/GLP-1 SIGNALLING RECOVERY IN TYPE 2 DIABETES AND NEURODEGENERATIVE DISEASES
Session Name
Session Type
PRE CONFERENCE SYMPOSIUM
Date
09.03.2021, Tuesday
Session Time
13:30 - 17:20
Room
Pre-Conference 2
Lecture Time
16:40 - 17:00
Presenter
- Ana I. Duarte, Portugal
Session Icon
NOVEL DUAL GLP-1/GIP RECEPTOR AGONISTS AND ARE SUPERIOR TO SINGLE RECEPTOR AGONISTS IN ANIMAL MODELS OF ALZHEIMER AND PARKINSON'S DISEASE
Session Name
Session Type
PRE CONFERENCE SYMPOSIUM
Date
09.03.2021, Tuesday
Session Time
13:30 - 17:20
Room
Pre-Conference 2
Lecture Time
17:00 - 17:20
Presenter
- Christian Hölscher, China
Session Icon